105 related articles for article (PubMed ID: 10801253)
21. Antiproteinuric effect of olmesartan in patients with IgA nephropathy.
Tomino Y; Kawamura T; Kimura K; Endoh M; Hosoya T; Horikoshi S; Utsunomiya Y; Yasuda T; Toyoda M; Tsuge T; Kaneko K
J Nephrol; 2009; 22(2):224-31. PubMed ID: 19384840
[TBL] [Abstract][Full Text] [Related]
22. Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.
Holdaas H; Fellström B; Jardine AG; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Logan JO; Staffler B; Gimpelewicz C;
Nephrol Dial Transplant; 2005 May; 20(5):974-80. PubMed ID: 15784644
[TBL] [Abstract][Full Text] [Related]
23. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis.
Cobos A; Jovell AJ; García-Altés A; García-Closas R; Serra-Majem L
Clin Ther; 1999 Nov; 21(11):1924-36. PubMed ID: 10890264
[TBL] [Abstract][Full Text] [Related]
24. Use of an indirect effect model to describe the LDL cholesterol-lowering effect by statins in hypercholesterolaemic patients.
Faltaos DW; Urien S; Carreau V; Chauvenet M; Hulot JS; Giral P; Bruckert E; Lechat P
Fundam Clin Pharmacol; 2006 Jun; 20(3):321-30. PubMed ID: 16671968
[TBL] [Abstract][Full Text] [Related]
25. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study.
Maschio G; Cagnoli L; Claroni F; Fusaroli M; Rugiu C; Sanna G; Sasdelli M; Zuccalà A; Zucchelli P
Nephrol Dial Transplant; 1994; 9(3):265-9. PubMed ID: 8052432
[TBL] [Abstract][Full Text] [Related]
26. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
Parinyasiri U; Ong-Ajyooth L; Parichatikanond P; Ong-Ajyooth S; Liammongkolkul S; Kanyog S
J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
[TBL] [Abstract][Full Text] [Related]
27. Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy.
Sakurai N; Kuroiwa T; Ikeuchi H; Hiramatsu N; Takeuchi S; Tomioka M; Shigehara T; Maeshima A; Kaneko Y; Hiromura K; Kopp JB; Nojima Y
Nephrol Dial Transplant; 2009 Aug; 24(8):2378-83. PubMed ID: 19188342
[TBL] [Abstract][Full Text] [Related]
28. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
Li PK; Leung CB; Chow KM; Cheng YL; Fung SK; Mak SK; Tang AW; Wong TY; Yung CY; Yung JC; Yu AW; Szeto CC;
Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
[TBL] [Abstract][Full Text] [Related]
29. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases.
Kobayashi Y; Fujii K; Hiki Y; Tateno S
Q J Med; 1986 Oct; 61(234):935-43. PubMed ID: 3628707
[TBL] [Abstract][Full Text] [Related]
30. Short-term effects of fluvastatin therapy on plasma interleukin-10 levels in patients with chronic heart failure.
Tekin A; Sezgin N; Katircibaşi MT; Tekin G; Cölkesen Y; Sezgin AT; Müderrisoğlu H
Coron Artery Dis; 2008 Nov; 19(7):513-9. PubMed ID: 18923248
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of fluvastatin in hyperlipidemic patients with chronic renal disease.
Yasuda G; Kuji T; Hasegawa K; Ogawa N; Shimura G; Ando D; Umemura S
Ren Fail; 2004 Jul; 26(4):411-8. PubMed ID: 15462110
[TBL] [Abstract][Full Text] [Related]
32. Effects of angiotensin-converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: a retrospective study in a single clinic.
Stiles KP; Abbott KC; Welch PG; Yuan CM
Clin Nephrol; 2001 Aug; 56(2):89-95. PubMed ID: 11522100
[TBL] [Abstract][Full Text] [Related]
33. Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model.
Kurinami H; Sato N; Shinohara M; Takeuchi D; Takeda S; Shimamura M; Ogihara T; Morishita R
Int J Mol Med; 2008 May; 21(5):531-7. PubMed ID: 18425343
[TBL] [Abstract][Full Text] [Related]
34. Plasma lipids and blood fluidity in patients with polygenic hypercholesterolaemia treated with fluvastatin.
Piñon F; Merino JF; Ferrer JC; Martínez M; Vayá A; Aznar J
Clin Hemorheol Microcirc; 2002; 27(3-4):193-9. PubMed ID: 12454376
[TBL] [Abstract][Full Text] [Related]
35. Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.
Manno C; Gesualdo L; D'Altri C; Rossini M; Grandaliano G; Schena FP
J Nephrol; 2001; 14(4):248-52. PubMed ID: 11506246
[TBL] [Abstract][Full Text] [Related]
36. Monitoring of peripheral blood cytotoxic T-cells under fluvastatin treatment in renal transplant recipients.
Barlage S; Hauser IA; Elbracht R; Abletshauser C; Schmieder RE; Weidinger G; Lackner KJ; Rothe G; Schmitz G
J Biol Regul Homeost Agents; 2005; 19(3-4):159-68. PubMed ID: 16602632
[TBL] [Abstract][Full Text] [Related]
37. Atorvastatin treatment in the short term: does it induce renoprotection or vasculoprotection in renal transplantation?
Navarro-Muñoz M; Bonet J; Bayés B; Lauzurica R; Blanco S; Romero R
Transplant Proc; 2007 Sep; 39(7):2259-63. PubMed ID: 17889157
[TBL] [Abstract][Full Text] [Related]
38. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
Kanno Y; Okada H; Saruta T; Suzuki H
Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
[TBL] [Abstract][Full Text] [Related]
39. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
40. Effects of lisinopril administration on blood bcl-2 concentrations in patients with immunoglobulin A nephropathy.
Buemi M; Allegra A; Corica F; Ruello A; Aloisi C; Pettinato G; Giacobbe M; Romeo A; Frisina N
Clin Pharmacol Ther; 1999 Jun; 65(6):649-52. PubMed ID: 10391670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
